TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 83 filers reported holding TANGO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,445,000 | +239.2% | 750,000 | 0.0% | 0.05% | +250.0% |
| Q2 2023 | $2,490,000 | -15.9% | 750,000 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $2,962,500 | -45.5% | 750,000 | 0.0% | 0.02% | -51.5% |
| Q4 2022 | $5,437,500 | +100.3% | 750,000 | 0.0% | 0.03% | +83.3% |
| Q3 2022 | $2,715,000 | -20.1% | 750,000 | 0.0% | 0.02% | -5.3% |
| Q2 2022 | $3,398,000 | -40.2% | 750,000 | 0.0% | 0.02% | -42.4% |
| Q1 2022 | $5,685,000 | -30.7% | 750,000 | 0.0% | 0.03% | -17.5% |
| Q4 2021 | $8,205,000 | -15.4% | 750,000 | 0.0% | 0.04% | -7.0% |
| Q3 2021 | $9,698,000 | – | 750,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $76,487,701 | 54.67% |
| Boxer Capital, LLC | 7,123,642 | $28,138 | 1.38% |
| Cormorant Asset Management, LP | 4,116,949 | $16,262 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $7,591 | 0.95% |
| EcoR1 Capital, LLC | 4,201,414 | $16,595,585 | 0.53% |
| Samsara BioCapital, LLC | 630,000 | $2,488,500 | 0.51% |
| Southpoint Capital Advisors LP | 4,500,000 | $17,775,000 | 0.40% |
| Casdin Capital, LLC | 1,000,000 | $3,950,000 | 0.32% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,798,121 | 0.29% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $790,000 | 0.12% |